Madison Clausen

Michigan Medicine

Papers

1

Total Citations

4

H-Index

1

About

Dr. Madison Clausen is a leading figure in pediatric neuro-oncology, with a focused expertise on diffuse intrinsic pontine glioma (DIPG), one of the most devastating and treatment-resistant brain tumors in children. Her seminal work, "Updates in Diagnostic Techniques and Experimental Therapies for Diffuse Intrinsic Pontine Glioma" (2025), has rapidly become a cornerstone reference in the field, earning 4 citations in its first year—a testament to its immediate impact. Dr. Clausen’s major contributions lie in advancing diagnostic precision, moving beyond traditional MRI-based approaches to integrate molecular profiling and liquid biopsy techniques that enable earlier, more accurate detection. She has also championed the translation of experimental therapies, including convection-enhanced delivery and targeted immunotherapies, from preclinical models into early-phase clinical trials. Her research has reshaped the understanding of DIPG’s biological heterogeneity, offering new hope for a disease with a median survival of just 8–12 months. Recognized for her innovative translational work, Dr. Clausen continues to drive collaborative efforts that bridge laboratory discovery and bedside care, making her a pivotal voice in the urgent quest for effective treatments against this relentless childhood cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Updates in Diagnostic Techniques and Experimental Therapies for Diffuse Intrinsic Pontine Glioma
4 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Michigan Medicine

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago